Literature DB >> 2893082

Prenatal testing for Duchenne and Becker muscular dystrophy.

C G Cole1, A Walker, A Coyne, L Johnson, K A Hart, S Hodgson, R Sheridan, M Bobrow.   

Abstract

DNA studies were undertaken following 53 requests from pregnant women at risk for Duchenne and Becker muscular dystrophy, including 32 in whom there was only 1 affected individual in the family (sporadic cases). The DNA restriction fragment length polymorphisms were informative in 51 of the 53 cases. In 10 of 25 pregnancies with male fetuses the risk to the fetus was reduced to 5% or less. Referral of possible carriers before onset of pregnancy is strongly advisable on both medical and economic grounds. The banking of DNA from affected individuals for future use in the estimation of risks to their relatives should be encouraged.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2893082     DOI: 10.1016/s0140-6736(88)90349-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  9 in total

Review 1.  Molecular biology of neurological diseases.

Authors:  W J Cumming
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

2.  Screening for Duchenne muscular dystrophy.

Authors:  R A Smith; M Rogers; D M Bradley; J R Sibert; P S Harper
Journal:  Arch Dis Child       Date:  1989-07       Impact factor: 3.791

3.  Duchenne muscular dystrophy in Wales: impact of DNA linkage analysis and cDNA deletion screening.

Authors:  A M Norman; M Upadhyaya; N S Thomas; K Roberts; P S Harper
Journal:  J Med Genet       Date:  1989-09       Impact factor: 6.318

4.  Detection of novel genetic markers by mismatch analysis.

Authors:  R G Roberts; A J Montandon; M Bobrow; D R Bentley
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

5.  Rapid carrier and prenatal diagnosis of Duchenne and Becker muscular dystrophy.

Authors:  R G Roberts; C G Cole; K A Hart; M Bobrow; D R Bentley
Journal:  Nucleic Acids Res       Date:  1989-01-25       Impact factor: 16.971

6.  Demand for DNA probe testing in three genetic centres in Britain (August 1986 to July 1987).

Authors:  R J Rona; A V Swan; R Beech; L Prentice; A Reynolds; O Wilson; G Mole; P Vadera
Journal:  J Med Genet       Date:  1989-04       Impact factor: 6.318

7.  Genotype-phenotype correlation and germline mosaicism in DMD/BMD patients with deletions of the dystrophin gene.

Authors:  A E Covone; M Lerone; G Romeo
Journal:  Hum Genet       Date:  1991-07       Impact factor: 4.132

8.  Prenatal diagnosis of Duchenne muscular dystrophy: prospective linkage analysis and retrospective dystrophin cDNA analysis.

Authors:  P A Ward; J F Hejtmancik; J A Witkowski; L L Baumbach; S Gunnell; J Speer; P Hawley; U Tantravahi; C T Caskey
Journal:  Am J Hum Genet       Date:  1989-02       Impact factor: 11.025

9.  Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification.

Authors:  J S Chamberlain; R A Gibbs; J E Ranier; P N Nguyen; C T Caskey
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.